韩正会见加拿大、丹麦客人（2026-06-18）

Han Zheng Meets with Canadian and Danish Guests (2026-06-18)

2026年6月18日，国家副主席韩正在北京分别会见加拿大工业部长乔利率领的知名企业家代表团、丹麦诺和诺德基金会主席兼诺和诺德公司董事会主席索文森。

On June 18, 2026, Vice President Han Zheng held separate meetings in Beijing. He met with a delegation of well-known entrepreneurs led by Joly, Canada's Minister of Industry, and with Sorenson, who chairs both the Novo Nordisk Foundation and the board of directors of Novo Nordisk.

在会见乔利一行时，韩正表示，今年1月，习近平主席同卡尼总理在北京成功举行会晤，达成一系列重要共识。中加两国经济互补性强，合作潜力巨大。中方愿同加方一道，落实好两国领导人重要共识，巩固传统领域合作，加强新能源汽车、人工智能等新兴领域合作，推动中加新型战略伙伴关系在健康、稳定、可持续的轨道上向前发展。

During his meeting with Joly and his delegation, Han Zheng stated that in January this year, President Xi Jinping and Prime Minister Carney held a successful meeting in Beijing, reaching important consensus on a series of major issues. China and Canada have highly complementary economies, and their cooperation holds enormous potential. China stands ready to work with Canada to implement the important consensus reached by the leaders of both countries, consolidate cooperation in traditional areas, strengthen cooperation in emerging fields such as new-energy vehicles and artificial intelligence, and advance the China–Canada new-type strategic partnership on a healthy, stable, and sustainable track.

乔利表示，加方高度重视发展对华关系，愿同中方深化企业互利合作，推动加中关系健康稳定发展。

Joly stated that the Canadian side attaches great importance to the sound and steady development of its relations with China, and is ready to deepen mutually beneficial cooperation between enterprises.

在会见索文森时，韩正表示，中国政府高度重视人民健康，“十五五”时期将加快建设健康中国，努力使人均预期寿命提高到80岁。希望诺和诺德公司发挥自身优势，积极参与健康中国建设。中方将继续扩大高水平对外开放，持续打造市场化、法治化、国际化一流营商环境，支持包括诺和诺德在内的广大外资企业在华更好发展。

When meeting with Sorenson, Han Zheng said that the Chinese government attaches great importance to people's health, and will accelerate the building of Healthy China during the 15th Five-Year Plan period, aiming to raise the average life expectancy to 80 years. It is hoped that Novo Nordisk will give full play to its strengths and actively contribute to the Healthy China initiative. The Chinese side will continue to expand high-standard opening-up, consistently foster a world-class business environment that is market-oriented, law-based, and internationalized, and support foreign-invested enterprises, including Novo Nordisk, in achieving even greater success in China.

索文森表示，诺和诺德公司看好中国经济发展前景，将继续拓展在华业务，参与中国医药行业发展，为健康中国建设作出更多贡献。

Sorenson stated that Novo Nordisk is optimistic about China's economic prospects, and will continue to expand its operations in China, participate in the development of China's pharmaceutical industry, and make greater contributions to the Healthy China initiative.